• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性核素证实硝酸异山梨酯在缓解贲门失弛缓症吞咽困难方面的治疗价值。

Radionuclide confirmation of the therapeutic value of isosorbide dinitrate in relieving the dysphagia in achalasia.

作者信息

Rozen P, Gelfond M, Salzman S, Baron J, Gilat T

出版信息

J Clin Gastroenterol. 1982 Feb;4(1):17-22. doi: 10.1097/00004836-198202000-00003.

DOI:10.1097/00004836-198202000-00003
PMID:7077059
Abstract

In fifteen patients with achalasia, we measured lower esophageal sphincter pressures before and after 5 mg of sublingual isosorbide dinitrate. The mean pressure fell significantly, from 36.5 to 18.4 mm Hg (P less than 0.01). The effectiveness of this therapy was confirmed by gamma camera measurement of the esophageal emptying time of a radionuclide test meal which was significantly less after the medication (P less 0.05). The emptying time was invariably longer than 10 minutes before therapy, and in 12 of the 15 patients decreased after therapy to 1-8 minutes, corresponding to the clinical response to the drug therapy. The noninvasive radionuclide technique provides a simple way of assessing the results of drug therapy in achalasia.

摘要

在15例贲门失弛缓症患者中,我们测量了5毫克舌下含服硝酸异山梨酯前后的食管下括约肌压力。平均压力显著下降,从36.5毫米汞柱降至18.4毫米汞柱(P小于0.01)。通过γ相机测量放射性核素试验餐的食管排空时间来证实该疗法的有效性,用药后食管排空时间显著缩短(P小于0.05)。治疗前排空时间总是超过10分钟,15例患者中有12例治疗后降至1 - 8分钟,这与药物治疗的临床反应相符。非侵入性放射性核素技术为评估贲门失弛缓症药物治疗的效果提供了一种简单方法。

相似文献

1
Radionuclide confirmation of the therapeutic value of isosorbide dinitrate in relieving the dysphagia in achalasia.放射性核素证实硝酸异山梨酯在缓解贲门失弛缓症吞咽困难方面的治疗价值。
J Clin Gastroenterol. 1982 Feb;4(1):17-22. doi: 10.1097/00004836-198202000-00003.
2
Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation.硝酸异山梨酯和硝苯地平治疗贲门失弛缓症:临床、测压及放射性核素评估
Gastroenterology. 1982 Nov;83(5):963-9.
3
Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid.硝酸盐对贲门失弛缓症下食管括约肌压力的影响:一种潜在的治疗辅助手段。
Gut. 1981 Apr;22(4):312-8. doi: 10.1136/gut.22.4.312.
4
Effect of isosorbide dinitrate and atropine on the lower esophageal sphincter pressure in Chagasic patients.硝酸异山梨酯和阿托品对恰加斯病患者食管下括约肌压力的影响。
Acta Physiol Pharmacol Latinoam. 1988;38(2):151-8.
5
Apparent complete lower esophageal sphincter relaxation in achalasia.
Gastroenterology. 1986 Apr;90(4):978-83. doi: 10.1016/0016-5085(86)90876-0.
6
Short report: comparison of the effects of sublingual nifedipine and isosorbide dinitrate on oesophageal emptying in patients with Chagasic achalasia.简短报告:比较舌下含服硝苯地平和硝酸异山梨酯对恰加斯病性贲门失弛缓症患者食管排空的影响。
Aliment Pharmacol Ther. 1992 Aug;6(4):507-12. doi: 10.1111/j.1365-2036.1992.tb00565.x.
7
Comparison of the effects of sublingual isosorbide dinitrate and cardiomyotomy on esophageal emptying in patients with chagasic megaesophagus.硝酸异山梨酯舌下含服与贲门肌切开术对恰加斯病性巨食管患者食管排空影响的比较。
Arq Gastroenterol. 1994 Apr-Jun;31(2):47-51.
8
Are the lower oesophageal sphincter relaxations in achalasia always incomplete? A manometric and scintigraphic study.贲门失弛缓症患者的食管下括约肌松弛是否总是不完全?一项测压和闪烁扫描研究。
Ital J Gastroenterol. 1990 Dec;22(6):342-5.
9
Use of isosorbide dinitrate for the symptomatic treatment of patients with Chagas' disease achalasia. A double-blind, crossover trial.硝酸异山梨酯用于恰加斯病失弛缓症患者的症状性治疗。一项双盲交叉试验。
Braz J Med Biol Res. 1991;24(11):1093-8.
10
Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction.贲门失弛缓症患者的治疗效果取决于食管胃结合部的可扩张性。
Gastroenterology. 2012 Aug;143(2):328-35. doi: 10.1053/j.gastro.2012.04.048. Epub 2012 May 2.

引用本文的文献

1
Medical management of painful achalasia: a patient-driven systematic review.贲门失弛缓症的医学治疗:以患者为导向的系统综述。
Dis Esophagus. 2024 Apr 27;37(5). doi: 10.1093/dote/doae005.
2
The management of esophageal achalasia: from diagnosis to surgical treatment.食管失弛缓症的治疗:从诊断到手术治疗。
Updates Surg. 2014 Mar;66(1):23-9. doi: 10.1007/s13304-013-0224-1. Epub 2013 Jul 2.
3
The chronic gastrointestinal manifestations of Chagas disease.恰加斯病的慢性胃肠道表现。
Clinics (Sao Paulo). 2009;64(12):1219-24. doi: 10.1590/S1807-59322009001200013.
4
A controversy that has been tough to swallow: is the treatment of achalasia now digested?一个难以咽下的争议:贲门失弛缓症的治疗现在是否被接受了?
J Gastrointest Surg. 2010 Feb;14 Suppl 1(Suppl 1):S33-45. doi: 10.1007/s11605-009-1013-5. Epub 2009 Sep 17.
5
Nitrates for achalasia.用于贲门失弛缓症的硝酸盐类药物。
Cochrane Database Syst Rev. 2004;2004(1):CD002299. doi: 10.1002/14651858.CD002299.pub2.
6
Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia.一项前瞻性临床和测压研究,比较气囊扩张术和舌下含服硝苯地平治疗食管贲门失弛缓症的效果。
Gut. 1991 Jun;32(6):604-6. doi: 10.1136/gut.32.6.604.